Our manuscript “Polygenic risk for schizophrenia and schizotypal traits in non-clinical subjects” was accepted for publication by Psychological Medicine (https://doi.org/10.1017/S0033291720002822).

Our manuscript “What we learn about bipolar disorder from large-scale neuroimaging: Findings and future directions from the ENIGMA Bipolar Disorder Working Group” was accepted for publication by Human Brain Mapping (https://doi.org/10.1002/hbm.25098).

Our manuscript “Improving early recognition and intervention in people at increased risk for the development of bipolar disorder: study protocol of a prospective-longitudinal, naturalistic cohort study (Early-BipoLife)” was accepted for publication by International Journal of Bipolar Disorders (https://doi.org/10.1186/s40345-020-00183-4).

Our manuscript “Brain structural correlates of schizotypal signs and subclinical schizophrenia nuclear symptoms in healthy individuals” was accepted for publication by Psychological Medicine (https://doi.org/10.1017/S0033291720002044).

Our manuscript “Long-term neuroanatomical consequences of childhood maltreatment: Re­duced amygdala inhibition by medial prefrontal cortex” was accepted for publication by Frontiers Systems Neuroscience (https://doi.org/10.3389/fnsys.2020.00028).

Our manuscript “Replication of a hippocampus specific effect of the tescalcin regulating variant rs7294919 on gray matter structure” was accepted for publication by European Neuropsychopharmacology (https://doi.org/10.1016/j.euroneuro.2020.03.021).

Our manuscript “Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group” was accepted for publication by Molecular Psychiatry (https://doi.org/10.1038/s41380-020-0754-0).

Our manuscript “The genetic architecture of the human cerebral cortex” was accepted for publication by Science (https://doi.org/10.1126/science.aay6690).